Between 2015 and 2021, the total amount of investments in research and development of the Italian pharmaceutical company Chiesi increased considerably. According to the data, indeed, expenses in this field went from 302 million euros in 2015 to over 479 million euros in 2021, the highest value registered in the period under consideration. This figure shows the worldwide R&D investments of the Italian pharmaceutical company Chiesi from 2015 to 2021.
Worldwide R&D investments of the Italian pharmaceutical company Chiesi from 2015 to 2021 (in million euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Revenue of the pharmaceutical group Bracco in 2016, by business unit
- Net result of pharmaceutical companies in Italy 2016-2018
- Leading pharmaceutical companies in Italy 2020, by revenue
- Production value of pharmaceutical companies in Italy 2016-2018
- Operating result of pharmaceutical companies in Italy 2016-2018
- Value added of pharmaceutical companies in Italy 2016-2018
- EBT of pharmaceutical companies in Italy 2016-2018
- RDPL total turnover FY 2017-2019
- HAL sales turnover FY 2014-2022
- Towa Pharmaceutical's total assets FY 2012-2017
- KAPL sales value FY 2014-2022
- RDPL production value 2014-2017
- KAPL production value FY 2014-2022
- HAL net profit FY 2014-2022
- Towa Pharmaceutical's employee numbers FY 2012-2017
- Otsuka Holdings' R&D spending 2011-2020
- Gland Pharma net debt FY 2018-2020
- Aurobindo Pharma's revenue from growth market formulations FY 2013-2021
- Gland Parma's CSR expenditure FY 2021
CHIESI Farmaceutici. (July 14, 2022). Worldwide R&D investments of the Italian pharmaceutical company Chiesi from 2015 to 2021 (in million euros) [Graph]. In Statista. Retrieved August 14, 2022, from https://www.statista.com/statistics/870872/worldwide-randd-investments-of-pharmaceutical-company-chiesi-in-italy/
CHIESI Farmaceutici. "Worldwide R&D investments of the Italian pharmaceutical company Chiesi from 2015 to 2021 (in million euros)." Chart. July 14, 2022. Statista. Accessed August 14, 2022. https://www.statista.com/statistics/870872/worldwide-randd-investments-of-pharmaceutical-company-chiesi-in-italy/
CHIESI Farmaceutici. (2022). Worldwide R&D investments of the Italian pharmaceutical company Chiesi from 2015 to 2021 (in million euros). Statista. Statista Inc.. Accessed: August 14, 2022. https://www.statista.com/statistics/870872/worldwide-randd-investments-of-pharmaceutical-company-chiesi-in-italy/
CHIESI Farmaceutici. "Worldwide R&d Investments of The Italian Pharmaceutical Company Chiesi from 2015 to 2021 (in Million Euros)." Statista, Statista Inc., 14 Jul 2022, https://www.statista.com/statistics/870872/worldwide-randd-investments-of-pharmaceutical-company-chiesi-in-italy/
CHIESI Farmaceutici, Worldwide R&D investments of the Italian pharmaceutical company Chiesi from 2015 to 2021 (in million euros) Statista, https://www.statista.com/statistics/870872/worldwide-randd-investments-of-pharmaceutical-company-chiesi-in-italy/ (last visited August 14, 2022)